Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2024-02-15 00:00:00 ET · period of report 2024-02-13 · accession 0001437749-24-004390 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-15 | 2024-02-13 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $23.55 | +4,242 | 16.7K | +34% | +$99.9K |
| D | 2024-02-15 | 2024-02-13 | LMAT | Roberts David B | Pres, Dir | M - OptEx | $0.00 | -4,244 | 122 | -97% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-13 | M | D | 2 | $0.00 | 16,680 | D | — | — | (F2) Represents shares from the release of fractional dividend equivalent rights returned to company. |
| 2 | Common | Common Stock | 2024-02-13 | M | A | 4,244 | $23.56 | 16,682 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-02-13 | M | D | 4,244 | $0.00 | 122 | D | $23.56 · 2018-12-19 to 2025-12-19 | 4,244 Common Stock | (F3) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |